|
KIAA1586 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.624500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.497400E-03 |
| Normal-vs-Stage2 |
2.776800E-01 |
| Normal-vs-Stage3 |
7.266000E-01 |
| Normal-vs-Stage4 |
8.228200E-01 |
| Stage1-vs-Stage2 |
7.862600E-01 |
| Stage1-vs-Stage3 |
5.416300E-03 |
| Stage1-vs-Stage4 |
7.761400E-03 |
| Stage2-vs-Stage3 |
3.582600E-01 |
| Stage2-vs-Stage4 |
3.358800E-01 |
| Stage3-vs-Stage4 |
9.046800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.712200E-02 |
| Normal-vs-AfricanAmerican |
4.146000E-01 |
| Normal-vs-Asian |
2.670400E-01 |
| Caucasian-vs-AfricanAmerican |
5.984000E-01 |
| Caucasian-vs-Asian |
8.166400E-01 |
| AfricanAmerican-vs-Asian |
6.365800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.696190E-01 |
| Normal-vs-Female |
5.364800E-03 |
| Male-vs-Female |
6.882100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.475200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.852400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.539560E-01 |
| Normal-vs-Age(81-100Yrs) |
9.293200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.781200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.291600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.644800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.224000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.009200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.001600E-03 |
| Normal-vs-Grade 2 |
6.373600E-04 |
| Normal-vs-Grade 3 |
4.804800E-01 |
| Normal-vs-Grade 4 |
2.798800E-01 |
| Grade 1-vs-Grade 2 |
3.381600E-01 |
| Grade 1-vs-Grade 3 |
1.640190E-02 |
| Grade 1-vs-Grade 4 |
1.203520E-03 |
| Grade 2-vs-Grade 3 |
9.437900E-04 |
| Grade 2-vs-Grade 4 |
1.71130999999658E-05 |
| Grade 3-vs-Grade 4 |
5.070400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.436280E-04 |
| Normal-vs-ccB subtype |
5.316800E-01 |
| ccA subtype-vs-ccB subtype |
6.593400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.260320E-02 |
| Normal-vs-N1 |
9.319200E-01 |
| N0-vs-N1 |
2.936400E-01 |
|
|
